Optimal Policies for Reducing Unnecessary Follow-Up Mammography Exams in Breast Cancer Diagnosis

被引:25
|
作者
Alagoz, Oguzhan [1 ]
Chhatwal, Jagpreet [2 ]
Burnside, Elizabeth S. [3 ]
机构
[1] Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI 53705 USA
[2] Univ Pittsburgh, Dept Hlth Policy & Management & Ind Engn, Pittsburgh, PA 15261 USA
[3] Univ Wisconsin, Dept Radiol, Madison, WI 53792 USA
基金
美国国家科学基金会;
关键词
Markov decision processes; double control limit policy; medical decision making; breast cancer diagnosis; mammography interpretation; practice; BI-RADS; PROBABLY BENIGN LESIONS; BI-RADS; AMERICAN-COLLEGE; SCREENING MAMMOGRAPHY; ALTERNATIVE VIEW; PREDICTIVE-VALUE; DATABASE FORMAT; VARIABILITY; BIOPSY; NETWORK;
D O I
10.1287/deca.2013.0272
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Mammography is the most effective screening tool for early diagnosis of breast cancer. Based on the mammography findings, radiologists need to choose from one of the following three alternatives: (1) take immediate diagnostic actions including prompt biopsy to confirm breast cancer; (2) recommend a follow-up mammogram; (3) recommend routine annual mammography. There are no validated structured guidelines based on a decision-analytical framework to aid radiologists in making such patient-management decisions. Surprisingly, only 15-45% of the breast biopsies and less than 1% of short-interval follow-up recommendations are found to be malignant, resulting in unnecessary tests and patient anxiety. We develop a finite-horizon discrete-time Markov decision process (MDP) model that may help radiologists make patient-management decisions to maximize a patient's total expected quality-adjusted life years. We use clinical data to find the policies recommended by the MDP model and also compare them to decisions made by radiologists at a large mammography practice. We also derive the structural properties of the MDP model, including sufficiency conditions that ensure the existence of a double control limit-type policy.
引用
收藏
页码:200 / 224
页数:25
相关论文
共 50 条
  • [21] The follow-up of breast cancer
    Emens, LA
    Davidson, NE
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 338 - 348
  • [22] Are unnecessary follow-up procedures induced by computer-aided diagnosis (CAD) in mammography? Comparison of mammographic diagnosis with and without use of CAD
    Marx, C
    Malich, A
    Grebenstein, U
    Sauner, D
    Facius, M
    Kaiser, WA
    RADIOLOGY, 2002, 225 : 116 - 116
  • [23] Are unnecessary follow-up procedures induced by computer-aided diagnosis (CAD) in mammography? Comparison of mammographic diagnosis with and without use of CAD
    Marx, C
    Malich, A
    Facius, M
    Grebenstein, U
    Sauner, D
    Pfleiderer, SOR
    Kaiser, WA
    EUROPEAN JOURNAL OF RADIOLOGY, 2004, 51 (01) : 66 - 72
  • [24] Breast cancer follow up; Is routine mammography indicated?
    Polak, Petr
    Beattie, Declan
    McIlmunn, Colin
    Kirk, Stephen
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [25] Breast Cancer Screening Using Convolutional Neural Network and Follow-up Digital Mammography
    Zheng, Yufeng
    Yang, Clifford
    Merkulov, Alex
    COMPUTATIONAL IMAGING III, 2018, 10669
  • [26] Scintimammography:: a new imaging technique for diagnosis and follow-up of breast cancer
    Hermans, J
    Bodart, F
    François, D
    Merlo, P
    Fauconnier, JP
    Schmitz, A
    Gérard, R
    de Ruyver, D
    Eeckhoudt, L
    BULLETIN DU CANCER, 2000, 87 (04) : 334 - 340
  • [27] DIAGNOSIS AND TREATMENT OF BREAST-CANCER RECURRENCES IN TUMOR FOLLOW-UP
    DELBRUCK, H
    MEDIZINISCHE WELT, 1986, 37 (19): : 614 - 617
  • [28] VALUE OF LABORATORY DIAGNOSIS IN FOLLOW-UP OF BREAST-CANCER PATIENTS
    SCHMIDTRHODE, P
    FRIEBE, M
    ZWIOREK, L
    SCHULZ, KD
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 814 - 816
  • [29] Breast cancer follow-up after a primary diagnosis: A confused picture
    Cruickshank, Susanne
    Barber, Matthew
    BREAST, 2019, 46 : 97 - 100
  • [30] Use of serum tumor markers for the diagnosis and follow-up of breast cancer
    Barrenetxea, G
    Schneider, J
    Llorente, MF
    ONCOLOGY, 1998, 55 (05) : 447 - 449